Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
LEVOSALBUTAMOL and BECLOMETASONE in Aerocort Inhaler: A Combination for Asthma Management
Introduction:
Aerocort Inhaler combines two active ingredients, Levosalbutamol, and Beclometasone, to effectively manage asthma symptoms such as wheezing and breathlessness. Levosalbutamol acts as a bronchodilator, relaxing the airway muscles, while Beclometasone, a steroid, addresses inflammation and allergic responses in the air passages.
Key Information:
Bronchodilator: Levosalbutamol
Steroid: Beclometasone
Route of Administration: Inhalation
Conditions Treated: Asthma, including wheezing and breathlessness
Uses:
LEVOSALBUTAMOL:
Treatment of Asthma: Addresses symptoms like wheezing and breathlessness.
Chronic Obstructive Pulmonary Disease (COPD): Useful in managing ongoing respiratory conditions.
BECLOMETASONE:
Severe Allergic Reactions: Manages severe allergic responses.
Allergic Conditions: Addresses various allergic conditions.
Skin Disorders: Useful in the treatment of skin disorders.
Eye Disorders: Addresses specific eye conditions.
Mechanism of Action:
LEVOSALBUTAMOL:
Bronchodilation: Acts as a bronchodilator by relaxing the muscles in the airways.
Airway Expansion: Expands the air passages, facilitating easier breathing.
BECLOMETASONE:
Anti-Inflammatory: Functions as a steroid by inhibiting the formation of certain chemical messengers that induce inflammation and allergies.
Inflammation Reduction: Reduces redness and swelling, alleviating allergic responses.